These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 10983692)
1. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. Lee KB; Kim UK; Lee CC J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692 [TBL] [Abstract][Full Text] [Related]
2. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974 [TBL] [Abstract][Full Text] [Related]
3. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis. Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894 [TBL] [Abstract][Full Text] [Related]
4. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477 [TBL] [Abstract][Full Text] [Related]
6. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178 [TBL] [Abstract][Full Text] [Related]
7. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. van Dijk MA; Breuning MH; Peters DJ; Chang PC Nephrol Dial Transplant; 2000 Jun; 15(6):836-9. PubMed ID: 10831637 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Schiavello T; Burke V; Bogdanova N; Jasik P; Melsom S; Boudville N; Robertson K; Angelicheva D; Dworniczak B; Lemmens M; Horst J; Todorov V; Dimitrakov D; Sulowicz W; Krasniak A; Stompor T; Beilin L; Hallmayer J; Kalaydjieva L; Thomas M Nephrol Dial Transplant; 2001 Dec; 16(12):2323-7. PubMed ID: 11733623 [TBL] [Abstract][Full Text] [Related]
9. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD. Lee KB; Kim UK Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120 [TBL] [Abstract][Full Text] [Related]
10. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD). Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958 [No Abstract] [Full Text] [Related]
11. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. Uemasu J; Nakaoka A; Kawasaki H; Ishikawa I; Yoshino Y; Shio H; Nemoto R; Nakamura I; Morio S Life Sci; 1997; 60(23):2139-44. PubMed ID: 9180368 [TBL] [Abstract][Full Text] [Related]
12. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Ecder T; McFann KK; Raynolds MV; Schrier RW Am J Nephrol; 2003; 23(6):466-70. PubMed ID: 14600431 [TBL] [Abstract][Full Text] [Related]
13. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease. Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132 [TBL] [Abstract][Full Text] [Related]
14. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease. Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of ACE DD genotype among north Indian end stage renal disease patients. Tripathi G; Dharmani P; Khan F; Sharma RK; Pandirikkal V; Agrawal S BMC Nephrol; 2006 Oct; 7():15. PubMed ID: 17042963 [TBL] [Abstract][Full Text] [Related]
16. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease. Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315 [TBL] [Abstract][Full Text] [Related]
17. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Konoshita T; Miyagi K; Onoe T; Katano K; Mutoh H; Nomura H; Koni I; Miyamori I; Mabuchi H Am J Kidney Dis; 2001 Jan; 37(1):113-118. PubMed ID: 11136175 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824 [TBL] [Abstract][Full Text] [Related]
19. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482 [TBL] [Abstract][Full Text] [Related]
20. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension. Zivko M; Kusec R; Galesić K Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]